Related Experiment Video

Updated: Apr 18, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

31.0K

HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export

Xian-Ming Du1, Mi-Jurng Kim1, Liming Hou1

  • 1From the Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia (X.-M.D., M.-J.K., L.H., S.P.C., C.M.Q., K.-A.R); INSERM, UMR_1166, Research Institute of Cardiovascular Disease, Metabolism and Nutrition, Pitié-Salpétrière University Hospital, Paris, France (W.L.G., M.J.C., A.K.); Université Pierre et Marie Curie-Paris 6, Paris, France (W.L.G., M.J.C., A.K.); Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden, The Netherlands (M.V.E.); Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA (L.K.C.); Department of Clinical Biochemistry, Royal Perth Hospital, Perth, Western Australia, Australia (J.R.B.); School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia (J.R.B.); Atherosclerosis Laboratory, ANZAC Research Institute, University of Sydney, Sydney, New South Wales, Australia (M.K., L.K., W.J.); and Department of Cardiology, Concord Hospital, Sydney, New South Wales, Australia (L.K.).

Circulation Research
|January 16, 2015
PubMed

Insights

Small, dense HDL particles, particularly HDL3b and HDL3c, are most effective at removing cholesterol from macrophages via the ABCA1 transporter. Therapies should aim to increase these specific HDL subfractions.

Area of Science:

  • Cardiovascular Biology
  • Lipid Metabolism
  • Macrophage Biology

Background:

  • High-density lipoprotein (HDL) is heterogeneous, with varying cholesterol efflux capacities.
  • Understanding HDL subfractions' roles is crucial for cardiovascular risk assessment and therapy development.
  • ATP binding cassette transporter A1 (ABCA1) mediates cholesterol efflux, but its role with lipidated HDL subfractions is unclear.

Purpose of the Study:

  • To identify HDL subfractions most efficient in cellular cholesterol efflux from macrophages.
  • To determine the specific cellular cholesterol transporters involved in this efflux process.

Main Methods:

  • Utilized reconstituted and human plasma-derived HDL subfractions.
  • Employed cell lines and primary macrophages with manipulated ABCA1 and ABCG1 expression.
  • Assessed cholesterol efflux capacity across different HDL sizes and compositions.

Main Results:

  • ABCA1 is the primary mediator of macrophage cholesterol efflux to HDL.
  • Small, dense HDL subfractions (HDL3b and HDL3c) showed the highest efficiency for ABCA1-mediated efflux.
  • ABCG1 plays a minor role in cholesterol efflux, with negligible contribution to efflux to HDL3b and HDL3c.

Conclusions:

  • Small, dense HDL subfractions are superior mediators of cholesterol efflux.
  • ABCA1 facilitates cholesterol efflux to both lipid-free apolipoprotein A-I and small, dense HDL.
  • Future HDL-targeted therapies should focus on enhancing small, dense HDL concentrations or efflux capacity.
Abstract